The two companies are vying for a share of Indias fast-expanding anti-obesity market, currently valued at Rs 3,0003,500 crore and projected to grow eightfold to Rs 25,000 crore by 2030
Existing studies also differ substantially in population, drug type, dose, treatment duration, follow-up window, endpoint definition, and control of gastrointestinal symptoms or other state-related confounders
doi:10.1007/s11926-021-01020-y Drio M, Benseor IM, Lotufo P, et al
SARS-CoV-2 could also induce GI inflammation, dysregulate intestinal ACE2 activity, and/or infect gut microflora (similar to bacteriophage-type transduction), as three potential inter-connected mechanisms in gut dysbiosis in PASC 253
Those gaps set up demand for dual and, later, triple receptor compounds